The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
Get this delivered to your inbox, and more info about our products and services.
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes drug has…
Frank Cappelleri of CappThesis breaks down the bullish technical backdrop for this pharma-related stock.
The investment bank upgraded the pharma stock to overweight from equal weight.
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing…
David Keller breaks down the technicals on this biotech giant.
Chart analyst Frank Cappelleri breaks down the technical outlook on the biotech stock.
